Prediction of organ-confined prostate cancer: incremental value of MR imaging and MR spectroscopic imaging to staging nomograms.
about
Imaging of prostate carcinomaThe role of magnetic resonance imaging (MRI) in focal therapy for prostate cancer: recommendations from a consensus panelAmide proton transfer MR imaging of prostate cancer: a preliminary study.Prostate cancer managed with active surveillance: role of anatomic MR imaging and MR spectroscopic imaging.Multimodal wavelet embedding representation for data combination (MaWERiC): integrating magnetic resonance imaging and spectroscopy for prostate cancer detection.Endorectal magnetic resonance imaging for predicting pathologic T3 disease in Gleason score 7 prostate cancer: implications for prostate brachytherapy.Radical prostatectomy: value of prostate MRI in surgical planning.Tumor volume changes on 1.5 tesla endorectal MRI during neoadjuvant androgen suppression therapy for higher-risk prostate cancer and recurrence in men treated using radiation therapy results of the phase II CALGB 9682 studyGuidance of treatment decisions in risk-adapted primary radiotherapy for prostate cancer using multiparametric magnetic resonance imaging: a single center experience.Focal therapy for prostate cancer - where are we in 2011?Prostate cancer: prediction of biochemical failure after external-beam radiation therapy--Kattan nomogram and endorectal MR imaging estimation of tumor volumePreoperative nomograms incorporating magnetic resonance imaging and spectroscopy for prediction of insignificant prostate cancerUpdated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005Performance characteristics of MR imaging in the evaluation of clinically low-risk prostate cancer: a prospective study.Nonvisible tumors on multiparametric magnetic resonance imaging does not predict low-risk prostate cancer.Preoperative 3-Tesla multiparametric endorectal magnetic resonance imaging findings and the odds of upgrading and upstaging at radical prostatectomy in men with clinically localized prostate cancer.Magnetic resonance imaging for prostate cancer clinical applicationProstate cancer magnetic resonance imaging (MRI): multidisciplinary standpoint.Imaging in genitourinary cancer from the urologists' perspective.Focal treatment or observation of prostate cancer: pretreatment accuracy of transrectal ultrasound biopsy and T2-weighted MRI.Multiparametric magnetic resonance imaging in prostate cancer: present and futureEvaluation of lactate and alanine as metabolic biomarkers of prostate cancer using 1H HR-MAS spectroscopy of biopsy tissues.Preoperative CT-based nomogram for predicting overall survival in women with non-endometrioid carcinomas of the uterine corpus.Advances in MR spectroscopy of the prostate.Technologies for localization and diagnosis of prostate cancer.Neoadjuvant therapy preceding prostatectomy for prostate cancer: rationale and current trials.Modalities for imaging of prostate cancer.MRI of the prostate: clinical relevance and emerging applications.Imaging in prostate cancer.A decade in prostate cancer: from NMR to metabolomics.Predictive value of MRI in the localization, staging, volume estimation, assessment of aggressiveness, and guidance of radiotherapy and biopsies in prostate cancer.Imaging in prostate cancer staging: present role and future perspectives.Formalized prediction of clinically significant prostate cancer: is it possible?Advances in oncologic imaging: update on 5 common cancers.Multiparametric magnetic resonance imaging in the management and diagnosis of prostate cancer: current applications and strategies.Multiparametric MRI for localized prostate cancer: lesion detection and staging.Implementation of Multi-parametric Prostate MRI in Clinical Practice.Prostate cancer risk stratification with magnetic resonance imaging.Integration of MRI to clinical nomogram for predicting pathological stage before radical prostatectomy.Hyperpolarized 13C lactate, pyruvate, and alanine: noninvasive biomarkers for prostate cancer detection and grading.
P2860
Q26865815-001A37DD-CA98-4DB2-B185-BAFCFD9D6D6BQ27006744-4973984A-7DFD-4DD1-BA2A-2BD27608EDF1Q33896220-E0ADE58C-DA81-47A5-BD30-D43D141380EDQ33964345-2FBD2F0B-0F77-496D-85AE-3EC9D97694FCQ34035596-6FFE3971-140F-4B02-9888-EE0338642B35Q34153708-1B120DD4-D8A2-4A0F-94C5-6403D0A2969EQ34223622-06EB4B99-0FD2-48CC-81F0-45AB7A5C8687Q34292169-3731BDBE-9CCA-4188-BB5C-71C9BA7BC36DQ35131928-02B321AB-E4E2-439B-B3A9-93585B08A46DQ35220196-E63AB33B-E40D-460B-90FE-50EF8B586E4CQ35407313-A239BA43-CA9B-4C95-A5B1-C4350BFC9757Q35722781-BF386B76-D603-4D51-A191-717C78FDFCC8Q36011880-7604C906-C252-42F6-A3DD-5984A7958427Q36346204-55F5E01E-49C6-434B-9797-EF4A51D7AF61Q36387925-05150ABF-8831-4F12-A64F-B5A5EAC4F812Q36532680-2BA449A3-FCF1-4CBF-8E0F-D68B296114EBQ36767668-49BF73E8-A8D3-4BCA-9380-1260944EEF87Q36795496-1B96AEB4-D355-4CF3-B903-4C3F1ED6CF54Q36834536-AAEAFF2E-D83B-4051-964B-EACE57A314B3Q36837246-7C62433E-902F-48BF-82D2-D70954F3A1B8Q37036294-0D76241A-3C9B-4EB6-A52F-C45BB1ABD7C2Q37036880-3591891D-0095-4B3B-A2AA-5E0733C65C3AQ37136039-07AE5055-BD64-4E44-BBD5-B2DBB004D419Q37300338-A290F95C-35FC-40E8-A32C-2A56268EFD27Q37619516-C6C99A18-B8C5-42D3-941E-ABB5605F1C18Q37705424-359470DE-8F85-499D-844F-E2FE02365EF0Q37719273-B272B51F-5734-4FF6-8BD8-85C1DFBBB37FQ37833011-DFB7ACAC-B382-4812-980C-5029F160BE4FQ37875083-537AEEE8-AEF8-4F1E-B639-4F95B81EA4E5Q37876681-2E58ECD7-3BB6-4533-840F-2D1A2C1CAF64Q37968978-C2B1212D-3449-4A2E-99F0-93F909188541Q37979650-9136FF6B-38A9-4B95-875A-9F6A93955C1DQ37988363-73B79733-9693-435B-B97C-F31BE9312583Q38052458-7310134E-9F17-4418-BF95-0938EFB1A609Q38178850-7C889D58-A3CB-461C-88F6-C988D477FAB3Q38294503-76E5E392-ACAF-4A09-AE49-AC08A040E404Q38528397-3819DE89-0608-4629-A5D2-5CAFB004644FQ38796980-A61C20C3-A4FC-444E-ADD5-F6AE7DBD5BC0Q39085006-CCE7090A-CD3E-4A37-9FB5-CFF3E06D17CFQ39301749-944AE8C2-D23A-466D-B3D1-7D75A68AC1E4
P2860
Prediction of organ-confined prostate cancer: incremental value of MR imaging and MR spectroscopic imaging to staging nomograms.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Prediction of organ-confined p ...... imaging to staging nomograms.
@ast
Prediction of organ-confined p ...... imaging to staging nomograms.
@en
type
label
Prediction of organ-confined p ...... imaging to staging nomograms.
@ast
Prediction of organ-confined p ...... imaging to staging nomograms.
@en
prefLabel
Prediction of organ-confined p ...... imaging to staging nomograms.
@ast
Prediction of organ-confined p ...... imaging to staging nomograms.
@en
P2093
P1433
P1476
Prediction of organ-confined p ...... imaging to staging nomograms.
@en
P2093
Hui-Ni Chen
Kentaro Kuroiwa
Liang Wang
Michael W Kattan
Peter T Scardino
P304
P356
10.1148/RADIOL.2382041905
P407
P577
2005-12-12T00:00:00Z